Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data Meeting Abstract

  

Authors:	Iyengar, N. M.; Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E.; Gajria, D.; Moynahan, M. E.; Traina, T. A.; Patil, S.; Liu, J.; Jochelson, M.; Norton, L.; Hudis, C. A.; Dang, C. T.
Abstract Title:	Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data
Meeting Title:	36th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title:	Cancer Research
Volume:	73
Issue:	24 Suppl.
Meeting Dates:	2013 Dec 10-14
Meeting Location:	San Antonio, TX
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2013-12-15
Language:	English
ACCESSION:	WOS:000209496901056
DOI:	10.1158/0008-5472.sabcs13-p2-16-07
PROVIDER:	wos
Notes:	Meeting Abstract: P2-16-07 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/99232